Mak Adam Daulatzai
Overview
Explore the profile of Mak Adam Daulatzai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
717
Followers
0
Related Specialties
Related Specialties
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daulatzai M
J Neurosci Res
. 2016 Jun;
95(4):943-972.
PMID: 27350397
Aging, hypertension, diabetes, hypoxia/obstructive sleep apnea (OSA), obesity, vitamin B12/folate deficiency, depression, and traumatic brain injury synergistically promote diverse pathological mechanisms including cerebral hypoperfusion and glucose hypometabolism. These risk factors...
2.
Daulatzai M
Neurotox Res
. 2016 Jun;
30(3):295-337.
PMID: 27339162
Sporadic Alzheimer's disease (AD) is a devastating neurodegenerative disorder. It is essential to unravel its etiology and pathogenesis. This should enable us to study the presymptomatic stages of the disease...
3.
Daulatzai M
Am J Neurodegener Dis
. 2016 Jun;
5(2):102-30.
PMID: 27335702
Alzheimer's disease (AD) is a chronic progressive neurodegenerative condition of the brain, and it is the most common cause of dementia. Several neurobiological etiologies of AD are described in the...
4.
Daulatzai M
Am J Neurodegener Dis
. 2016 Apr;
5(1):1-28.
PMID: 27073740
Alzheimer's disease (AD) is a chronic progressive neurodegenerative condition of the brain, and it is the most common cause of dementia. Several neurobiological etiologies of AD are described in the...
5.
Daulatzai M
Curr Pharm Des
. 2016 Feb;
22(16):2411-30.
PMID: 26845126
Despite advances in understanding the pathophysiology of Alzheimer's disease (AD), its therapy remains largely symptomatic and supportive. Acetylcholinesterase inhibitors - the first-line drugs used today do not prevent and treat...
6.
Daulatzai M
J Neurosci Res
. 2015 Aug;
93(12):1778-94.
PMID: 26301370
The incidence of dementia and obstructive sleep apnea (OSA) increases with age. Late-onset Alzheimer's disease (AD) is an irreversible neurodegenerative disease of the elderly characterized by amyloid β (Aβ) plaques...
7.
Daulatzai M
J Neural Transm (Vienna)
. 2015 May;
122(10):1475-97.
PMID: 25944089
We interact with the physical world through our senses, and these aid our behavioral performance and various activities of life. Sensory information is transmitted in neuronal networks, and the brain...
8.
Daulatzai M
Neurotox Res
. 2015 Apr;
28(1):55-93.
PMID: 25911292
Brain damage begins years before substantial neurodegeneration and Alzheimer's dementia. Crucial fundamental activities of life are breathing, eating, drinking, and sleeping. When these pivotal functions are maligned over a prolonged...
9.
Daulatzai M
CNS Neurol Disord Drug Targets
. 2015 Feb;
14(1):110-31.
PMID: 25642988
The non-celiac gluten sensitivity (NCGS) is a chronic functional gastrointestinal disorder which is very common world wide. The human gut harbors microbiota which has a wide variety of microbial organisms;...
10.
Daulatzai M
Curr Top Behav Neurosci
. 2014 Aug;
18:265-96.
PMID: 25167923
Late-onset Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the most common cause of progressive cognitive dysfunction and dementia. Despite considerable progress in elucidating the molecular pathology of this...